Pentobarbital capabilities throughout the CNS by binding to gamma-aminobutyric acid (GABA) A subtype receptors. This action potentiates GABA effects, resulting in CNS despair and inhibiting glutamate, even further resulting in an additive effect on CNS despair. Even though the lack of an antidote has resulted in lessened initially-line utilization